Enacts the overdose prevention and recovery act; directs that at least twenty percent of funds from the opioid stewardship fund shall be invested in recovery services and supports; requires an annual report to the legislature regarding funds distributed from the opioid stewardship fund; makes the opioid stewardship fund permanent.
A00069 would enact the “overdose prevention and recovery act” and revise how New York’s opioid stewardship fund is used. The bill requires that money in the fund be used for opioid treatment, recovery, prevention, education, and related programs, and it adds a new requirement that at least 20% of the fund be invested in recovery services and supports and at least 20% be allocated to the Department of Health for harm reduction services, including syringe service programs and drug user health hubs. It also clarifies that the fund may support the prescription monitoring program registry and that the money must supplement, not replace, existing federal, state, or local funding.
The bill also creates a detailed annual reporting requirement. Beginning one year after the effective date, the commissioners of the Office of Addiction Services and Supports and the Department of Health must submit a public dashboard-style report to the governor and legislative leaders describing baseline funding, how opioid stewardship funds were spent, who received the money, what services were provided, what populations were served, the criteria used to make awards, and an evidence-based assessment of program effectiveness. The report is intended to improve transparency and inform future appropriations.
In terms of state law, the bill amends the State Finance Law and the 2018 opioid stewardship act. Most notably, it removes the current sunset date that would otherwise repeal the opioid stewardship fund on June 30, 2029, effectively making the fund permanent. It also updates references from the former Office of Alcoholism and Substance Abuse Services to the Office of Addiction Services and Supports, and it expands the statutory purposes for which fund money may be transferred and used.
The general sentiment reflected by the bill text and sponsorship is supportive of expanding and stabilizing opioid response funding, with an emphasis on recovery and harm reduction rather than only treatment and enforcement. No committee transcript or vote data is provided, so there is no recorded floor or committee debate to gauge broader legislative sentiment. Based on the bill’s structure, it appears designed to strengthen accountability and ensure dedicated funding for overdose prevention and recovery services.
The main point of contention likely concerns the mandated funding split and the inclusion of harm reduction services such as syringe service programs and drug user health hubs, which can be politically sensitive. Another possible issue is the bill’s requirement that funds not supplant existing spending, which could affect agency budgeting and how recipients are selected. Supporters are likely to favor the guaranteed allocations and transparency measures, while critics may question the rigidity of the set-asides, the permanence of the fund, or the scope of harm reduction programming.
This bill would amend the State Finance Law and the 2018 opioid stewardship act to make the opioid stewardship fund permanent, require minimum allocations for recovery and harm reduction, and impose annual public reporting on fund use and effectiveness. It would affect the Office of Addiction Services and Supports, the Department of Health, state budget officials, and any agencies or providers receiving opioid stewardship funding, while also reinforcing the non-supplanting rule for existing federal, state, and local funds.
The bill appears broadly supportive of overdose prevention, recovery, and harm reduction strategies, with a clear emphasis on transparency and dedicated funding. Because no committee transcript or vote history is provided, there is no direct evidence of formal opposition or amendment debate, but the bill’s design suggests a coalition favoring stronger, more permanent opioid response funding and accountability.
Likely points of contention include the requirement that at least 20% of funds go to recovery services and at least 20% to harm reduction services, especially syringe service programs and drug user health hubs. Some stakeholders may also object to making the fund permanent, to the reporting burden, or to the bill’s non-supplanting language if it constrains budget flexibility. Supporters would likely argue these provisions ensure stable, targeted, and measurable use of opioid settlement-related funds.